BHC - Company ID 0000885590
The table below shows Bausch Health Companies Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $230.00M | $211.00M | $211.00M | $154.00M | -$63.00M | $443.00M |
| Capital expenditure | $109.00M | $115.00M | $82.00M | $47.00M | $46.00M | $66.00M |
| Investing cash flow | -$139.00M | -$130.00M | -$73.00M | -$78.00M | -$56.00M | -$56.00M |
| Dividends paid | - | - | - | - |
Bausch Health Companies Inc. reported operating cash flow of $1.40B for fiscal year 2025. That is down 12.3% from $1.60B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $2.09B (FY 2016) to $1.40B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$100.00M | -$146.00M | -$340.00M | -$142.00M | $468.00M | -$243.00M |